News and blogs
332 results found.
Blood Cancer UK funding led to understanding the origins of childhood leukaemia in twins
New research has shed light on the origins on a type of blood cancer – childhood acute lymphoblastic leukaemia – and how it develops in children.
New ‘universal approach’ therapy for leukaemia shows promise during world-first trial
Blood Cancer UK was proud to fund the lab studies that directly led to this life-changing trial which could broaden the number of people who benefit from this type of therapy in future.
Paxlovid rebound: what we know
Paxlovid is the most commonly prescribed treatment for people with severe immunosuppression who test positive for covid-19. We look at the phenomenon called Paxlovid rebound and what it might mean for the future of Paxlovid treatment.
Evusheld available in the UK to buy privately
Evusheld is available privately in the UK. Here’s what we know about how to access it.
New campaign launches for the forgotten 500,000 families
Patient groups, charities and clinicians unite to raise awareness of half a million vulnerable people, many of whose lives have never returned to normal after Covid-19 lockdown. The campaign is calling for the Government to reverse its decision and immediately roll out Evusheld for the immunosuppressed.
Health inequalities: how does stress change our bodies?
You might not have heard of "allostatic load" before, but scientists are learning more and more about how chronic stress adds to the ‘wear and tear’ on our bodies, the way it differs between ethnicities and leads to health inequality.
Sidney Farber - The Father of Modern Chemotherapy
Dr Sidney Farber was an American paediatric pathologist. He discovered the role folic acid played in the creation of leukaemia cells and achieved the first clinical remission of leukaemia in children by using a chemical anti agent.
Chief Executive Gemma Peters announces her departure
We are sad to announce that our chief executive, Gemma Peters, will be leaving Blood Cancer UK.
Celebrating September
For Blood Cancer Awareness Month, Jonathan shares his story in memory of his dad Ian whose MGUS developed into Acute Myeloid Leukaemia. Ian sadly died in May 2022; just 8 weeks after his diagnosis.
Remembering Her Majesty the Queen
Over half of UK adults unable to name single blood cancer symptom
As we enter Blood Cancer Awareness Month, we're highlighting the massive crisis of awareness in blood cancer. Despite blood cancer being the UK’s third biggest cancer killer, one in four people would be unlikely to go to their GP if they had any of the main symptoms
What's the latest on Evusheld?
Many people living with blood cancer will be deeply disappointed by the news that the Government will not make Evusheld available until an appraisal (a full assessment) of the drug has been completed. We are also devastated by this announcement and are continuing to campaign for it to be bought and made available on the NHS immediately. Here's an update on what we’re doing, along with some information about the context of the Government's decision.
Facts and information about blood cancer
Blood cancer is the UK’s third biggest cancer killer, and yet awareness and understanding of it is much lower than for other types of cancer.
Five things we learned about blood cancer services from the Cancer Patient Experience Survey
Every year, NHS England asks thousands of cancer patients in England about their experiences. We've picked out five key things we think the NHS and Government should be focusing on, which we believe would save a significant number of lives.
Over 120 leading clinicians have signed a clinical consensus statement, declaring that the Covid-19 protective antibody treatment Evusheld should be used as soon as possible to protect people most vulnerable to Covid-19.
Over 120 leading clinicians have signed a clinical consensus statement, declaring that the Covid-19 protective antibody treatment Evusheld should be used as soon as possible to protect people most vulnerable to Covid-19.
Blood cancer and covid: making choices that work for you
We know it's still an uncertain time for the blood cancer community, with many people trying to find the right balance between protecting themselves from the virus and looking after their mental well-being.
Survey highlights forgotten pandemic victims
As the country as a whole returns to normal, a quarter of people with blood cancer remain anxious about leaving their home
Did you know people affected by blood cancer help decide what research we fund?
For the first time at Blood Cancer UK, this year a group of 16 people affected by blood cancer reviewed all applications received by us for research funding.
Our strategy: How will we approach partnerships in future?
We're currently refreshing our strategy to ensure we learn the lessons from the COVID-19 pandemic and are ready and able to meet the challenges of the next five years. We've undertaken this together with people affected by blood cancer, who have been alongside us as we moved rapidly through the process. Today we have an update on how we'll approach partnerships.
Our strategy: How we're going to build our community
As we continue with our series of blogs explaining our work around our strategy, today we look at how we plan to reach more people affected by blood cancer.